Clinical Trial Update: Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the effect of rosuvastatin on in vivo kinetics of apoB and apoA1 in patients with type 2 diabetes mellitus using stable isotopes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CRESTOR (Rosuvastatin)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Diabetes | Phase 4 | Status: COMPLETED